T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.58B |
| 2 |
T-Mobile US
TMUS
|
+$1.53B |
| 3 |
Morgan Stanley
MS
|
+$1.15B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.15B |
| 5 |
Apple
AAPL
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.94B |
| 2 |
Amazon
AMZN
|
+$2.82B |
| 3 |
GE Aerospace
GE
|
+$1.93B |
| 4 |
Goldman Sachs
GS
|
+$1.88B |
| 5 |
ServiceNow
NOW
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.25% |
| 2 | Healthcare | 17.75% |
| 3 | Financials | 11.32% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Maravai LifeSciences
MRVI
$861M
| $13.7M | ﹤0.01% |
974,740
+4,215
| +0.4% | +$60.5K |
|
1002
Fox Class A
FOXA
$27.5B
| $13.6M | ﹤0.01% |
398,001
-2,908
| -0.7% | -$98.2K |
|
1003
Carnival Corporation Ltd
CCL
$38.9B
| $13.5M | ﹤0.01% |
1,331,601
+66,945
| +5% | +$693K |
|
1004
Fomento Económico Mexicano
FMX
$39.7B
| $13.4M | ﹤0.01% |
+140,600
| New | +$12.3M |
|
1005
iShares Core S&P 500 ETF
IVV
$910B
| $13.3M | ﹤0.01% |
32,451
+8,321
| +34% | +$3.34M |
|
1006
Orchestra BioMed
OBIO
$267M
| $13.3M | ﹤0.01% |
680,547
-5,254
| -0.8% | -$60.8K |
|
1007
Robert Half
RHI
$4.48B
| $13.2M | ﹤0.01% |
163,300
+3,038
| +2% | +$241K |
|
1008
Schrodinger
SDGR
$1.38B
| $13.1M | ﹤0.01% |
498,568
+469,872
| +1,637% | +$11.2M |
|
|
NVRO
1009
DELISTED
NEVRO CORP.
NVRO
| $13.1M | ﹤0.01% |
362,329
+81,895
| +29% | +$2.88M |
|
1010
Transocean
RIG
$6.39B
| $13M | ﹤0.01% |
2,039,368
+1,834,048
| +893% | +$11.8M |
|
1011
Molson Coors Class B
TAP
$7.85B
| $12.9M | ﹤0.01% |
250,032
+7,050
| +3% | +$365K |
|
1012
Vistra
VST
$49.1B
| $12.7M | ﹤0.01% |
530,378
-340,007
| -39% | -$7.88M |
|
1013
American Airlines Group
AAL
$9.97B
| $12.6M | ﹤0.01% |
855,206
+19,905
| +2% | +$310K |
|
|
OZON
1014
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $12.6M | ﹤0.01% |
1,798,842
-1,226,514
| -41% | -$8.59M |
|
1015
Ardagh Metal Packaging
AMBP
$3.16B
| $12.6M | ﹤0.01% |
3,079,617
+41,949
| +1% | +$206K |
|
1016
Dorman Products
DORM
$3.95B
| $12.5M | ﹤0.01% |
145,066
-126,550
| -47% | -$11.3M |
|
1017
Tenaya Therapeutics
TNYA
$164M
| $12.5M | ﹤0.01% |
4,386,783
-85,419
| -2% | -$240K |
|
|
BWIN
1018
Baldwin Insurance Group
BWIN
$2.99B
| $12.3M | ﹤0.01% |
484,866
+1,671
| +0.3% | +$46.4K |
|
1019
HEICO Corp
HEI
$51.9B
| $12.3M | ﹤0.01% |
71,868
+56,526
| +368% | +$9.52M |
|
1020
Ardelyx
ARDX
$1.01B
| $12.3M | ﹤0.01% |
2,561,796
+265,370
| +12% | +$895K |
|
1021
KBR
KBR
$4.81B
| $12.2M | ﹤0.01% |
220,806
+161,275
| +271% | +$8.44M |
|
1022
Universal Health Services
UHS
$10.1B
| $12M | ﹤0.01% |
94,440
-153
| -0.2% | -$21.1K |
|
1023
NRG Energy
NRG
$25.2B
| $11.9M | ﹤0.01% |
346,612
+3,474
| +1% | +$115K |
|
1024
Tandem Diabetes Care
TNDM
$1.61B
| $11.8M | ﹤0.01% |
291,191
+925
| +0.3% | +$38.3K |
|
1025
Pentair
PNR
$10.7B
| $11.8M | ﹤0.01% |
213,460
+5,958
| +3% | +$316K |
|
Similar funds
T. Rowe Price Associates's Q1 2023 Portfolio in Review
As of Q1 2023, T. Rowe Price Associates held 3,020 positions worth $668B, up 7.5% from $622B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2023 filing shows 65 new, 1,711 increased, 924 reduced and 98 closed positions. Its largest new stake was Suncor Energy: 6,437,236 shares worth $200M. The largest sale was Alphabet (Google) Class C, an estimated $2.94B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2023 buy was Suncor Energy: 6,437,236 shares worth $200M.
- T. Rowe Price Associates added most to Tesla in Q1 2023, an estimated $1.58B increase.
- T. Rowe Price Associates's biggest Q1 2023 reduction was Alphabet (Google) Class C, cutting an estimated $2.94B.
- T. Rowe Price Associates fully exited Signature Bank in Q1 2023, selling an estimated $360M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $668B portfolio in Q1 2023.
- T. Rowe Price Associates opened 65 new positions and closed 98 in Q1 2023.
- T. Rowe Price Associates's portfolio value rose 7.5% quarter-over-quarter to $668B.
Based on T. Rowe Price Associates's 13F filing for Q1 2023, filed 15 May 2023.